By inhibiting metalloproteinase inhibitor 3 (TIMP3), miR-206 has also been shown to attenuate cardiac fibrosis in the setting of chronic heart failure (Limana et al., 2011). The gene discussed is TIMP3; the disease is congestive heart failure.